SK
Sonic Healthcare Limited
SKHHY · OTC
$13.60 +0.19% (+$0.03)
1M -13.57%
Market Cap $9.37B
P/E Ratio 15.74x
Div. Yield 5.39%
ROE 7.12%
Bulios Fair Price
$19.19
41.1% upside
Current Price
$13.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SKHHY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
92 /100
Cheap P/E 15.74x
P/FCF 12.36x
EV/EBITDA 7.61x
Growth
29 /100
Declining EPS growth 6.11%
Book val. growth 2.53%
Rev. growth 10.38%
Profitability
45 /100
Moderate Gross margin 27.65%
FCF margin 7.08%
Net margin 5.56%
Quality
34 /100
Average ROIC 5.50%
Asset turnover 0.64x
ROE 7.12%
Debt
54 /100
Moderate Debt/Equity 0.70x
Net debt/EBITDA 2.71x
Current ratio 0.99x
Stability
96 /100
Stable Beta 0.59x
Profitable years 6
Rev. volatility 2.18%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SKHHY
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James Pacey Newcombe
Employees
43,000
Headquarters
Sydney
Upcoming events
22 FEB
Earnings
Upcoming earnings report